These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

884 related items for PubMed ID: 10375085

  • 1. Mycosis fungoides and the Sézary syndrome.
    Kim YH, Hoppe RT.
    Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
    [Abstract] [Full Text] [Related]

  • 2. Mycosis fungoides.
    Zinzani PL, Ferreri AJ, Cerroni L.
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):172-82. PubMed ID: 17950613
    [Abstract] [Full Text] [Related]

  • 3. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT.
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [Abstract] [Full Text] [Related]

  • 5. Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis.
    Smith BD, Wilson LD.
    Oncology (Williston Park); 2003 Sep; 17(9):1281-8. PubMed ID: 14569854
    [Abstract] [Full Text] [Related]

  • 6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [Abstract] [Full Text] [Related]

  • 7. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.
    J Clin Oncol; 2010 Nov 01; 28(31):4730-9. PubMed ID: 20855822
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Myocosis fungoides--an update on a non-mycotic disease.
    Makdisi J, Friedman A.
    J Drugs Dermatol; 2013 Jul 01; 12(7):825-31. PubMed ID: 23884501
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mycosis fungoides: cutaneous T-cell lymphoma.
    Zaim MT, Grinkemeyer MD.
    Am Fam Physician; 1991 May 01; 43(5):1703-7. PubMed ID: 2021105
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A practical approach to accurate classification and staging of mycosis fungoides and Sézary syndrome.
    Thomas BR, Whittaker S.
    Skin Therapy Lett; 2012 Dec 01; 17(10):5-9. PubMed ID: 23223768
    [Abstract] [Full Text] [Related]

  • 15. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb 01; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [Abstract] [Full Text] [Related]

  • 16. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
    Grob JJ, Horchowski N, Tubiana N, Gabriel B, Gastaut JA, Hassoun J, Jouve I, Carcassone Y, Bonerandi JJ.
    Dermatologica; 1988 Feb 01; 177(2):82-97. PubMed ID: 3262542
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, Bonello L, Bernengo MG.
    Br J Dermatol; 2005 Sep 01; 153(3):565-73. PubMed ID: 16120144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.